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Abstract
The novel SARS-CoV-2 strain (COVID-19) was identified in Wuhan, China in December
2019 (Eddy et. al, 2020). The resulting US outbreak has affected the Kaiser Permanente (KP)
Oakland health care system. With the threat of COVID-19 highest among immunosuppressed
and elderly clients, KP Oakland home health and hospice (HH/HO) department is rapidly
mobilizing to provide community and in-home testing for eligible clients. A project was created
to build a COVID-19 testing team workflow to provide diagnostic and preventative testing. This
project focuses on team-based interventions that will change the pre-existing practice of
requiring HH/HO clients to travel to remote testing sites or outpatient facilities for COVID-19
specimen collection. COVID-19 sampling in a home environment reduces the risk of community
spread and allows those who cannot travel to have the means to be tested (Kumari et. al, 2020).
The mitigation strategies for COVID-19 in the home environment must include specimen
collection competencies, testing workflows, and creating case definitions for implementing
testing practices. Per current national guidelines and KP mitigation strategies, clinical testing for
COVID-19 is strongly recommended for symptomatic patients and required for asymptomatic
patients receiving care in acute and outpatient procedural settings (see appendix A).
Outcome measures for this project include the number of HH/HO clients tested by the new
KP Oakland testing team, compared to the number of HH/HO patients requiring testing at
outside facilities or agencies. The newly developed workflow also tracks the amount of days
from COVID-19 test order to testing date.

3
COVID-19 TESTING TEAM
Introduction
Problem Description
The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11,
2020 (WHO, 2020). The incubation period of the COVID-19 is about 2 to 14 days and
transmitted by respiratory droplets and close contact (Rahimzadeh et. al, 2020). Reported
illnesses have ranged from mild to severe symptoms and, potentially, death. Significant
symptoms include fever, cough, shortness of breath, pneumonia, and other respiratory tract
involvement complications (Rahimzadeh et. al, 2020). Health care providers are managing
patient symptoms using respiratory therapy, steroids, oxygen supplementation, and medications
to expel mucus from the lungs. In severe cases, treatments to support organ function are
necessary (Hamm, 2020).
The community spread of COVID-19 has proved to be widespread and ongoing. Proper
planning and preparedness is critical for maintaining healthcare services during the ongoing
COVID-19 pandemic (CDC, 2020). As the healthcare system becomes increasingly complex and
intertwined, different healthcare professionals are often required to work closely as part of an
interprofessional healthcare team (Welsch et. al, 2018). It has been reported that effective
teamwork and collaboration within healthcare teams improves the delivery of care and thus
positively impacts patient outcomes (Welsch et. al, 2018). In response to a regional health crisis,
education and leadership needs to be rapid and involve the multidisciplinary team working
together to bridge practice gaps (Peterson et. al, 2020).
This project aimed to decrease the number of clients tested remotely and increase the
number of tests completed in the home environment.Prior to the integration of a COVID-19
testing workflow, HH/HO clients that required testing were mainly routed to other agencies
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outside of KP Oakland. The benchmark data on COVID-19 testing in May 2020, 3 clients were
tested at remote testing centers, and 2 clients were tested in the home environment. Before
introduction of this change project, the KP Oakland HH/HO testing rate was 66%, and the goal
of this project was to provide 95% of all COVID-19 testing for HH/HO clients that meet the
testing case definition.
Providing quality specimen collection and testing procedure amid the global pandemic
poses unique challenges, especially to the preexisting staff workflow for lab collection (Liebert,
2020). Specific testing practices need to be put into place, including testing in the home
environment for HH/HO clients, the use of personal protective equipment (PPE) and infection
control practices for obtaining specimens (see Appendix B). The unique aspect of a HH/HO
department is the variable environments for healthcare workers to provide care and treat clients.
In a fragmented microsystem, it is key to streamline all diagnostic and procedural care to ensure
that all healthcare workers are meeting agency competencies. Clients experiencing COVID-19
symptoms should be tested early and efficiently to aide in developing a plan of care.
Available Knowledge
The community resources and home care of KP Oakland’s HH/HO department are
constantly being tested and improved. In the COVID-19 pandemic, it is crucial that the HH/HO
department continually responds in a timely manner with home testing workflows, adequate PPE
and testing resources and safe handling and transport of specimen to the laboratory. The PICO
question (see Appendix C) for this change project revolves around the development of COVID19 testing protocols for the home environment. The outcome of this project is the improved
testing workflow for HH/HO clients. In comparison, without a change project to create a testing
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workflow, faulty or unsafe COVID-19 testing can negatively affect client outcomes and quality
of life.
In HH/HO patients, quality COVID-19 testing by the established healthcare team directly
increases patient health outcomes and satisfaction (WHO, 2020). By implementing home testing
as safely and timely as possible, the hospice and home health clients can receive adequate
epidemiological care, regardless of mobility and ability to travel.
Largely due to the variable protocols across Northern California and nationally, a
preliminary literature review of COVID-19 testing procedures and workflows yielded mixed
results. The search terms for the literature review included the key terms of “COVID-19 testing
in the home environment” and “COVID-19 testing in a hospice facility”. The literature review
was conducted using the database source CINAHL. A total of sixteen sources were reviewed and
included in this paper. Included in the literature review were eleven sources from the United
States, two from the United Kingdom, one from Singapore, one from Iran and one from India.
The literature review included ten published evidence-based research articles, two excerpts from
published textbooks, and four internet pages published by respected sources, including the World
Health Organization (WHO) and the Center for Disease Control and Prevention (CDC).
A key component of this project was identifying the case definition for testing clients that
receive services from the KP Oakland HH/HO department. It would be illogical and unnecessary
to test every client on service; instead, a case definition must be developed to elucidate when
testing is necessary. Implementing case definitions is an epidemiological requirement to
standardize criteria for identification of cases (Pan American Health Organization, 1999). For the
purposes of this project, an asymptomatic case refers to a client being tested for COVID-19
without any symptoms or any known exposure. There are many reasons for an asymptomatic test
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to be performed, including client transfer to a long-term care facility or an upcoming procedure
that requires admittance to a hospital, other acute facility, or outpatient facility. A symptomatic
case is a test ordered on a client exhibiting COVID-19 symptoms.
Rationale
The rationale for this project was to standardize the practice of sample collection using a
team-based approach for a population of HH/HO patients. Utilizing a framework that helps guide
changes suggested by evidence-based literature, the ACE Star Model of Knowledge
Transformation is well adapted not only to facilitate nursing change, but to better understand the
knowledge behind that change (see Appendix D). Developed by faculty at the University of
Texas, the model has five aspects, including discovery of knowledge, a summary of evidence,
translating the evidence into clinical practice, integrating the recommended change into practice,
and then evaluating the outcomes once the changes are incorporated (see Appendix D).
Using the ACE Star Model (see Appendix D), the interventions are sustainable through the
re-evaluation process, allowing for adjustment and continuous improvement. One aspect of the
ACE Star Model that applies well to the HH/HO COVID-19 Community Testing Team is an
ingrained understanding that clinical information and research is the basis for successful change
process. The crucial step of knowledge transformation allows for the systematic organization of
knowledge and application of knowledge opportunity. The ACE Star Model is a collaborative
process that works well with other improvement methods, including the Model for Improvement
(MFI). Advocated by the Institute for Healthcare Improvement (IHI), the MFI asked three simple
questions: What are we trying to accomplish? How will we know the change is an improvement?
What change can we make that will result in improvement? (Langley et al. 2009).
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Specific Project Aim
Providing quality home health and hospice care amid the global pandemic poses unique
challenges, especially related to COVID-19 testing procedures and staff workflow (Liebert,
2020). Following both the CDC and the KP agency standards, a workflow was developed. As
time progressed, and the pandemic has evolved, the expected outcomes remained the same for
the purpose of this project. This change project was implemented to meet a specific aim:
By August 05, 2020, the KP Oakland Home Health and Hospice department will provide
95% of all COVID-19 testing for clients meeting both symptomatic and asymptomatic
testing requirements, and will provide testing within 72 hours from physician order.
Methods
Context
The IHI developed a Cultural Assessment Tool (see Appendix E) that enables
organizations and agencies to determine the cultural environment through questions about safety,
disclosure of adverse events, and client perception of care. Using this tool, an assessment of the
microsystem was completed and revealed an environment ready and willing to incorporate
change to the infection control and safety workflows. The staff already participate in ongoing
training and continued learning, and a culture of safety is supported through just policies for
reporting, safety protocols and a commitment to timely communication.
In a HH/HO department, Strengths, Weaknesses, Opportunities and Threats (SWOT)
analyses are completed to assess the organization’s current situation before deciding on a new
strategy for change (see Appendix F). SWOTs provide healthcare leaders with a quick and
simple overview of the microsystem and its processes. Moreover, SWOT analyses can provide
high-quality information to stakeholders and personnel, and can demonstrate the microsystem’s
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preparedness for upcoming threats (Ruffinen et. al, 2015). At the KP Oakland HH/HO
department, the unique strengths include clear and efficient leadership over a highly specialized,
sufficient amount of staff for testing. Also, the KP regional organization supports this program
and there is considerable buy-in from the nursing staff, who want a safe and reliable way to test
HH/HO clients.
A fishbone diagram was created to delve into the various reasons for an increased need
for a HH/HO COVID-19 testing workflow (see Appendix G). The fishbone diagram is a tool to
determine various factors that contribute to a primary concern or problem in a microsystem. This
change project revolves around testing processes, and therefore the fishbone reflects the different
aspects that coalesced into a need for a community testing team and subsequent workflow. As
many HH/HO clients are immobile and unable to travel to remote sites, key factors of the
fishbone diagram include the high risk of contracting COVID-19 in the community outpatient
setting and the increased risk of exposure from family.
For this project, the KP Oakland HH/HO department has many resources available to
assist the development and sustainability of new workflows. Return on investment (ROI) is a
performance measure that calculates a company’s resultant cash flow after change is initiated. As
this change project is implemented across the microsystem, the ROI was predetermined by
regional HH/HO directors to be sufficient for the development and sustainability of the
workflow. Per current CDC guidelines and agency mitigation strategies, PPE is supplied for
every home health and hospice visit indefinitely. Face masks and face shields are a required for
every home visit, regardless of the level of care provided. Masks cost approximately 0.6-1.9
cents per mask depending on type, pricing, availability etc. Additionally, nurses completing
COVID-19 testing wear gloves and don gowns for symptomatic tests.
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Four nurses were trained to perform COVID-19 testing through a five-hour session
completed on one day. The average HH/HO nurse salary at KP can range from $50-55.
Approximate loss for the education session is $1,050 in wages, and does not include the cost for
transportation and cost of collaboration with training personnel. Data collection, completed by a
clinical nurse leader over a 25 week period, at $72/hour calculates out to $1,250 for data
collection. No other initial start-up costs are evident.
Interventions
After identifying a need for testing among clients on service, the KP Oakland HH/HO
department strategized how best to implement a COVID-19 testing workflow in late May of
2020. Rolled out in June 2020, an internal workflow was initially developed through team
collaboration. A specific number of registered nurses were selected to receive education on swab
testing for COVID-19 and proper donning and doffing protocol of PPE. At this time, four nurses
have received such education and achieved competency. The nurses were sent to observe and
learn directly from the healthcare workers at the “drive-thru” testing sites set up by the regional
Kaiser Permanente and located throughout Northern California. It took approximately 5 hours, in
a one day period, to complete this training.
After a physician’s order is acknowledged by the KP Oakland HH/HO department for a
client’s COVID-19 test, the Quality Director notifies the interdisciplinary team of a potential
symptomatic case vs asymptomatic case. One of the trained registered nurses is then assigned to
this specific client’s case for the COVID-19 test. These visits are restricted to only obtaining the
specimen for lab testing; the nurse is instructed to refrain from providing other care for the client
due to the time constraints on the refrigerated specimen. The standard PPE for KP Oakland
currently includes a face mask, face shield, and gloves, all of which is appropriate for an
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asymptomatic test. After obtaining the specimen through proper swabbing technique, the nurse
exits the client’s home whilst maintaining proper infection control protocols. The next step in
this workflow is the lab, where the nurse must drop off the COVID-19 testing swab within one to
two hours of collection. The specific location of the lab is pre-determined, based off of the
distance and availability of the labs partnered with KP Oakland HH/HO. The nurse completes a
warm hand-off with a laboratory supervisor for the test to be acknowledged.
Clients that present with symptoms of COVID-19 and require a test from the KP Oakland
HH/HO are classified as “patients under investigation” (PUI). A PUI mandates that the nurse
follow stricter PPE requirements (i.e. gown) and an observer role to be present and available
throughout the entire testing process. The observer role can be completed by physical therapists,
occupational therapists, home health aide, or another registered nurse. All members of the
interdisciplinary team meet competencies for proper donning and doffing procedure of PPE (see
Appendix B). The observer remains outside the residence/testing environment for the procedure,
and observes how the nurse dons and doffs PPE, handles the specimen, and helps with providing
the proper insulated bag for the testing swab. This role is assigned for the swab test only, and the
observer does not enter the home environment.
The last piece is the specific documentation for a COVID-19 test. Set forth by the larger
regional KP agency, specific parameters for diligent documentation include the testing time,
patient tolerance, lab information, and observer presence. At the KP Oakland HH/HO agency,
the quality director monitors the tests and documentation, ensuring that the specimen arrived at
the lab within the appropriate time frame and was received by the proper personnel. Once the lab
results are known, the quality director follows up with the client’s healthcare team immediately
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for both asymptomatic and symptomatic cases. In the occurrence of a positive, symptomatic
client, the interdisciplinary team moves forward and identifies a care plan for the client.
Measures
A critical part of testing and implementing change is diligent and meaningful
measurement that indicates improvement (“Science of Improvement”). For this change project, a
balanced set of measures was used for all improvement efforts, including outcomes measures,
process measures, and balancing measures (see Appendix H). The outcomes measures for this
project include the number of patients tested by the KP Oakland HH/HO. According to the
benchmark data obtained in May 2020, only 2 clients were able to be tested by healthcare
providers through KP Oakland HH/HO, and 3 clients had to travel to remote testing centers.
Translated into a percentage, KP Oakland HH/HO’s goal was to reach 95% of all COVID-19
testing for clients that met case definitions. Process measures, which study if the change is
performing as planned, include the days from order to testing date. The microsystem and testing
team was given a goal of under 72 hours between the time of the test being ordered and the nurse
performing the COVID-19 test in the home environment. This is a regionally-accepted
timeframe, and was consistently met by both KP Oakland HH/HO and other remote testing sites
prior to this new workflow introduction. Finally, balancing measures for this project are the
patients identified by personnel for testing that do not meet the current case definition for
specimen collection.
Ethical Considerations
The rare and special aspect of HH/HO care is the client’s supreme right to privacy; the
client resides in their own environment, and spends large chunks of time free from healthcare
professionals and support staff invading their space or territory (Scott et. al, 2003). In regards to
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informational privacy, the client’s electronic health record is accessed through the testing nurse’s
departmentally-issued laptop or tablet, and accesses the internet using a VPN. The process of
data collection involves chart auditing and only tracks the total number of asymptomatic versus
symptomatic cases. This data does not incorporate any protected health information. In regards
to autonomy, COVID-19 testing is only completed on clients who consent to testing. Autonomy,
or the ability to act according to one’s knowledge and judgment, is sustained through nursing
care within existing professional, regulatory, and organizational rules. A self-assessment was
completed to determine if this change project met ethical requirements. This project’s aim and
methods do not come into conflict with commonly recognized values. Additionally, this project
does not involve identifiable persons. No potential conflicts of interest were identified.
Results
Change projects require a timeline chart to identify when to approach goals and when to
measure the change (see appendix I). A chart was developed after the onset of the COVID-19
pandemic to help the microsystem’s leaders identify necessary steps for creating a testing
workflow. The chart included dates for project conception, implementation and evaluation. The
initial steps of the chart outline the time for project definition, aims and measures development,
primary literature review, identification of changes to test, creation of the testing team and
coordination of staff training. The project roll-out began on April 24, 2020. By May 8, 2020,
workflows were developed through multiple interprofessional collaborative meetings; testers
were trained and met competency standards for COVID-19 testing by May 15, 2020. A driver
diagram was created to identify the order in which certain tasks needed to be implemented
throughout the project timeline (see appendix J). Included in the driver diagram is the flow from
the creation of the testing team into the wider tasks of education and creation of workflows.
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Over the course of the project, various factors affecting the success of the change were
identified and required new methods and adjustments. For example, the observer role was
introduced after a need for an extra support staff during testing was identified. Additionally, a
specific time frame for data collection had to be established to determine a clear point to stop and
take an overview of the project and data. There were no unexpected costs associated with this
project. Although much national and global attention around PPE shortages extended throughout
this project, the regional KP organization mitigated such shortages appropriately and the
microsystem never had to ration PPE.
Benefits of this change project were identified through data review and tester feedback.
Personal, informal interviewing of testers gave valuable insight to the testing process and aided
workflow modifications and sustainability. The testers of the microsystem reported feeling safe
and supported in the testing and specimen handling process. Reviewing charts and tracking cases
is a continual process that ensures clients can be tested in an appropriate time frame.
Discussion
Summary
In March 2020, COVID-19 was declared a pandemic and was catapulted into a primary
concern for healthcare agencies across the United States. KP Northern California mobilized
quickly to develop new standards of practice for testing, specimen handling, data collection and
organization of testing resources. In a home health and hospice population, invasive diagnostic
procedures are not generally a standard for care; however, it became clear that developing a
COVID-19 testing workflow was necessary after HH/HO clients required both symptomatic
testing and asymptomatic testing by April and May of 2020.
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The key findings of this project indicate that the COVID-19 community testing team
workflow is successful. A total of 26 symptomatic tests and 97 asymptomatic tests were
performed by the KP Oakland HH/HO community testing team (see Appendix K). A combined
total of 123 tests were performed between June 15, 2020 and September 28, 2020. This project
far exceeded the projected goal of 75 completed COVID-19 tests (see Appendix H). A total of
four clients were diverted for testing through other agencies; therefore, approximately 97% of
HH/HO clients that met the case definition received testing through the KP Oakland community
testing team. This exceeds the project charter goal of 95%. As this project surrounds workflow
development and efficiency, a successful percentage of testing is key for the sustainability of this
new testing team to continue through the COVID-19 pandemic.
Conclusion
COVID-19 diagnosis and treatment continues to be a challenging issue, as infection and
mortality rates increase and cause significant expenditures on the United States healthcare
system. Community spread of COVID-19 is projected to spike through November and December
of 2020 and extend into the spring of 2021. This change project was developed during an integral
period of the pandemic and need for COVID-19 testing will still be prevalent after the official
end of this project. The developed workflow of testing for COVID-19 is sustainable for
continuation and will be further led by quality improvement leaders and nursing staff in the
microsystem. Implications for other microsystems and mesosystems include the potential for the
workflows to become established practices in the regional KP departments of Northern
California. Additionally, this project could be adapted for testing clients in long-stay acute
rehabilitation centers, nursing homes and residential facilities.
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Appendix C
PICO Question

P
Patient,
Population or
Problem
hospice and
home health
clients meeting
the case
definition for
COVID-19
testing

I

C

O

Intervention or
exposure

Comparison

Outcome

testing &
specimen
collection
workflows

faulty, unsafe
workflow or
protocol to test
clients for
COVID-19

improved testing
workflow for
home health and
hospice clients.
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Appendix E
IHI Assessment Tool—A Culture of Respect, Communications, and Disclosure

Internal Culture
of Safety

Malpractice
Carrier
Policies,
Guidelines,
Procedures

Training
Disclosure
Processes in
Place
The Disclosure

Ongoing Support

Resolution
Learning

Element**

Y

The organization is grounded in the core values of compassion and respect and
the ethical responsibility to always tell the truth to the patient and family.
There is an expectation for ongoing communication, honesty, and transparency
that is set from the board and leadership and closely monitored.
Error is seen as the failure of systems and not people.
All can expect support at the sharp end of unanticipated outcome and near-miss.
There is a commitment to rapid disclosure and support.
There is a written understanding of how cases will be managed in partnership
between patient/family/carrier.
Mechanisms are in place for rapid respectful resolution.
There is a policy on patient and family communications.
There is a policy on patient and family partnerships.
Organizational infrastructure for clinician support exists.
There are policies on disclosure and documentation.
Procedures are known and in place for internal and external communication of
sentinel events.
Guidelines/policies support a fair and just culture (non-punitive) and the reporting
of adverse events.
There is a written crisis communication plan. This plan is centrally located and
easily accessible by all staff.
Ongoing training programs are in place for all staff on communication,
expectations, policies, procedures, guidelines.
There is just-in-time coaching (training) for disclosures.
There is rapid notification of patient/family and activation of support—typically
immediately around what is known.
There is a team to support staff preparing to disclose (coaches).
Root cause analyses commence immediately, are closely managed, and the
results are shared, including with the patient and family.
The organization is transparent and honest.
Responsibility is taken.
We apologize/acknowledge.
There is a commitment to providing follow-up information.

Y

The caregiver is supported throughout the process.
The organization provides continuing support for the patient/family.
All hospital staff disclosing are trained in their role
Resources are available to assist families experiencing unanticipated outcomes
(not limited to error) – support is defined by needs of the patient and family (e.g.,
emotional support).
Resources are available to assist staff at the sharp end of unanticipated
outcomes (not limited to error) – based on the needs of the clinician (e.g.,
emotional support).
Procedures are in place and are known to ensure ongoing communications with
patients, families, and staff.
Procedures are in place and are known to bring the case to closure respectfully,
as viewed by the patient and family.
Mechanisms are in place to ensure learning by the board, executive leadership,
MSEC, and across the organization.
Measurement systems are in place to assess the impact of communication,
disclosure, and support (as well as quality and safety) practices on premiums,
claims, cases, and payments.

Y
Y
Y
Y

Y
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Y
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Y
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Appendix F
SWOT Analysis

- Clear clinical leadership
- Buy in from nursing staff
- Nurses specialized in palliative
and hospice care
- Clear guidance from regional
organization
- Sufficient staff numbers for
testings

- Vague & disorganized national
guidance on COVID-19
guidelines and testing
procedures
- Potential shortages of
PPE/swabs
- Variable testing competencies

- Directly providing COVID-19
resources to HH/HO clients
- Inform clients early and reduce
the risk of transmission through
education
- Reduction of inappropriate
interventions/screenings
- Allow clients to be tested
without travelling

- Potential for HH/HO personnel
to contract and spread COVID19
- Screenings may be seen as
unnecessary by the family/client
- Poor information processes
means key prognostic
information is not shared
effectively

- F
-

-

26
COVID-19 TESTING TEAM
Appendix G
Fishbone Diagram
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Appendix H
IHI Science of Improvement: Family of Measures Assessment

Measures, Outcomes, Processes and Balancing
Measure

Data Source

Target

KPHC Report

75 patients

Outcome Measures
# Home Health/Hospice patients
tested by KP Community Testing
Team

# patients requiring testing at test site Agency Spreadsheet
or hospital

2 patients

Process Measures
Days from Order to Testing Date

KPHC Report

72 hours from request to test

Balancing Measures
Patients ID’d who don’t require a test Case Definitions
due to not meeting the current case
definitions criteria

2 patients
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Appendix I
Project Timeline
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Appendix J
Driver Diagram from Project Charter
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Appendix K
Run Chart and Total Testing Results

Total Symptomatic Tests: 26
Total Asymptomatic Tests: 97
Total Tests Diverted through Other Agencies: 4

